Effect of implementing a novel calf vitality scoring system and early intervention program on pain management in newborn dairy calves

Authors

  • S. M. Godden Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gartner Ave., St. Paul, MN 55108
  • W. A. Knauer Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gartner Ave., St. Paul, MN 55108
  • C. Gapniski Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gartner Ave., St. Paul, MN 55108
  • K. Yorek Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gartner Ave., St. Paul, MN 55108
  • R. Hullinsky Department of Veterinary Population Medicine, College of Veterinary Medicine, University of Minnesota, 1365 Gartner Ave., St. Paul, MN 55108
  • K. Leslie Department of Population Medicine, University of Guelph, 50 Stone Road E, Guelph, Ontario, NlG 2W1, Canada
  • S. McGuirk Department of Medical Sciences, University of Wisconsin, School of Veterinary Medicine, 2015 Linden Drive, Madison, WI 53706
  • H. Coetzee Department of Anatomy & Physiology, Kansas State University, Manhattan, KS 66506

DOI:

https://doi.org/10.21423/aabppro20183217

Keywords:

Pain management, dystocia, VIGOR scoring system, scoring system, non-steroidal anti-inflammatory, meloxicam

Abstract

Pain management in newborn calves after dystocia and assisted calving is still not addressed by most producers or veterinarians. The calf VIGOR scoring system, developed at the University of Guelph, was designed to be applied within minutes after birth to assesses Visual appearance, Initiation of movement, General responsiveness, Oxygenation, and heart and respiration Rates in calves. The VIGOR scoring system was designed to identify high risk/low vigor calves for the purpose of applying interventions to improve vigor and survivability. In different studies conducted at the University of Guelph it was reported that providing pain management with a non-steroidal anti-inflammatory (meloxicam), shortly after birth, may improve calf vitality, health and performance outcomes, particularly in calves experiencing dystocia. The objective of this study was to conduct a randomized controlled trial to evaluate the effect of implementing a novel program that includes assessment of newborns using the VIGOR scoring system followed by provision of meloxicam to calves with low vigor scores, on outcomes reflecting calf well-being and health.

Downloads

Published

2018-09-13

Issue

Section

Research Summaries

Most read articles by the same author(s)

1 2 3 4 5 > >>